By Matthew Holt Today at 12 noon PST Aneesh Chopra, Federal CTO will be at the Commonwealth Club in San Francisco talking about health care and health care IT. Indu and I saw him last night talking about technology before…  Read More →

By Matthew Holt Unplatforms is the term I’ve been using to describe the multitude of devices that people are using to collect and receive information. And also to cover the different channels they are using often on the same device…  Read More →

By Matthew Holt Ingenix, the arms dealer that’s been supplying all sides in the health care information war for the past decade or so, built itself up by buying lots of little companies in the data analytics space. Now it’s…  Read More →

By Matthew Holt Saturday’s New York Times portends more trouble for big Pharma. The headline is wrapped up in an examination of foreign corrupt practices, but the bigger issue is that clinical trials have hidden serious adverse events. The recent…  Read More →

By Matthew Holt Earlier this week there was a curious little hearing at Pete Stark’s committee. Much of the Q & A—mind you post the announcement of the final meaningful use rules—was (apparently, as I can’t find the transcript) a…  Read More →

By Matthew Holt One of my favorite topics is back in the news. Apparently ACL repairs may be unnecessary. Here’s the WSJ Health Blog write up about the NEJM study. Two groups of active young people with torn ACLs were…  Read More →

By Matthew Holt Ever since the “build your own network” company Ning moved to a pay model for its networks, there’s been some browbeating on the blogosphere about what to do with those communities which had created traction on Ning,…  Read More →

By Matthew Holt Josh Seidman has written from ONC telling us about a fantastic job opportunity. You get to work with the brilliant folks at ONC on fun stuff regarding consumer e-Health. What does that mean? From the posting. Forge…  Read More →

By Matthew Holt Absolutely hot off the recorder, here’s my interview with David Blumenthal, National Coordinator for Health IT. He discusses patient communication, why the percentages of certain criteria were reduced, and how to get the two Reginas on Oprah…  Read More →

By Matthew Holt More than a year or so of squabbling is (sort of) over and today HHS announced its criteria for the first phase of meaningful use. Essentially the 25 criteria for qualifying for “meaningful use” (in other words…  Read More →

By Matthew Holt A few weeks back we welcomed John Goodman as a contributor at THCB. His first column was more than a tad critical of me for impugning the ethics of Harvard Business School Prof Regina Herzlinger. Herzlinger, you…  Read More →

By Matthew Holt Gena Cook is the CEO of Navigating Cancer, a new Health 2.0 company aiming at getting cancer patients online with their care providers. Gena tracked me down in a Starbucks in Seattle (oxymoron I know) when I…  Read More →

By Matthew Holt This week the AP published a long piece about overtreatment at the end of life. I encourage you to read it. The article featured the story of Za: The doctors finally let Rosaria Vandenberg go home. For…  Read More →

By Matthew Holt At the AHIP conference in Vegas earlier this month I sat down with the CEO of Alere, Tom Underwood, and long-time friend of The Health Care Blog, Gordon Norman (Alere’s SVP of Innovation). I asked Tom about…  Read More →

By Matthew Holt A couple of weeks back two New York Times reporters (Abelson & Harris) decided to take on the orthodoxy of the Dartmouth school. Frankly their efforts reminded me of England’s performance in the world cup so far—abject…  Read More →